Howard R. Higley

Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial

Heiko Schöder, Mei‐Yin C. Polley, Michael V. Knopp et al. · Blood · 2020 · 94 citations · Full text

Medicine, Nuclear Medicine, Oncology +8

Antigens Specified by the Tla Locus Are Expressed on the Surface of Murine Langerhans Cells

Geoffrey Rowden, Bishnupriya Misra, Howard R. Higley et al. · Journal of Investigative Dermatology · 1983 · 92 citations · Full text

Life Sciences, Cell Biology, Immunology +8

The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications

Kenneth C. Anderson, Daniel Auclair, Gary J. Kelloff et al. · Clinical Cancer Research · 2017 · 91 citations

Medicine, Hematology, Immunology +17

Developmental expression of adenosine deaminase in the upper alimentary tract of mice

Jeffrey M. Chinsky, V. Ramamurthy, William C. Fanslow et al. · Differentiation · 1990 · 69 citations

Life Sciences, Biochemistry, Molecular Biology +10

Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer

Gary J. Kelloff, Ronald Lieberman, Vernon E. Steele et al. · Urology · 2001 · 66 citations

Medicine, Oncology, Pharmacology +14